Ribavirin levels at treatment weeks (TW) 4-6 can predict sustained viriological response (SVR12) in HCV cirrhotic patients treated with all oral direct-acting antiviral therapy (DAAs)
Journal article published in 2015 by
Suman Verma,
Ivana Carey,
Kate E. Childs,
Andrew Ayers,
Phillip Morgan,
Aisling B. Considine,
Kath Oakes,
Michael A. Heneghan,
Graham R. Foster,
Kosh Agarwal 
